REAL-WORLD DATA ANALYSIS OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATMENT DECISIONS WITH THE INTRODUCTION OF NEWER TREATMENT OPTIONS

被引：0
|
作者：
Scott, J. [1 ]
Concepcion, R. [1 ]
Garofalo, D. [1 ]
Verma-Kurvari, S. [1 ]
Xu, B. [1 ]
Montgomery, J. [1 ]
机构：
[1] Integra Connect, W Palm Beach, FL USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.246
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN199
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [31] Real-world PROCEED registry data: Sipuleucel-T in elderly men with metastatic castration-resistant prostate cancer (mCRPC).
    Armstrong, Andrew J.
    Olsson, Carl A.
    Schnadig, Ian D.
    Concepcion, Raoul S.
    Vacirca, Jeffrey L.
    Tutrone, Ronald F.
    Dakhil, Shaker R.
    Chang, Nancy N.
    Tang, Hong
    Brown, Bruce
    Vogelzang, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [32] New treatment options for patients with metastatic castration-resistant prostate cancer
    Higano, Celestia S.
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 340 - 345
  • [33] Real-world management of metastatic castration-resistant prostate cancer (mCRPC): A national multicenter cohort study.
    Lavallee, Luke
    Morash, Chris
    Saad, Fred
    Yip, Steven
    Kapoor, Anil
    Kolinsky, Michael Paul
    Pouliot, Frederic
    Antebi, Elie
    Drachenberg, Darrel
    Ferrario, Cristiano
    Gotto, Geoffrey
    Hamilton, Robert James
    Ko, Jenny J.
    Noonan, Krista
    So, Alan
    Malone, Shawn
    Zardan, Anousheh
    Chi, Kim N.
    Hotte, Sebastien J.
    Niazi, Tamim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [34] Real-world treatment landscape in advanced metastatic castration resistant prostate cancer
    Sacchi, Elizabeth
    Singhal, Hari
    Zamalloa, Jose
    Sanchez, Beatriz Lopez
    Zhang, Ke
    Parihar, Harish
    Greshock, Joel
    Max, Steven I.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Treatment of metastatic castration-resistant prostate cancer (mCRPC); Survival by type of progression at initiation of treatment
    Robbrecht, D. G.
    van Soest, R. J.
    Tannock, I. F.
    Oudard, S.
    Tombal, B.
    Eisenberger, M.
    Mercier, F.
    de Wit, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [36] Treatment of metastatic, castration-resistant prostate cancer
    von Amsberg, G.
    Merseburger, A. S.
    UROLOGE, 2020, 59 (06): : 673 - 679
  • [37] First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry
    Galli, Luca
    Chiuri, Vincenzo Emanuele
    Di Lorenzo, Giuseppe
    Pisconti, Salvatore
    Rossetti, Sabrina
    Sirotova, Zuzana
    Muto, Andrea
    Petrioli, Roberto
    De Tursi, Michele
    Sbrana, Andrea
    Francolini, Giulio
    Ardizzoia, Antonio
    Scavelli, Claudio
    Satta, Francesco
    Quadrini, Silvia
    Airoldi, Mario
    D'Aniello, Carmine
    Bonetti, Andrea
    Conforti, Serafino
    Aieta, Michele
    Beccaglia, Patrizia
    Maestri, Antonio
    Fratino, Lucia
    TUMORI JOURNAL, 2023, 109 (02): : 224 - 232
  • [38] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Bilusic, Marijo
    Karzai, Fatima
    Cordes, Lisa M.
    Strauss, Julius
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Karzai, Fatima
    Cordes, Lisa M.
    Schlom, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [40] Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer
    Halwani, Ahmad S.
    Rasmussen, Kelli M.
    Patil, Vikas
    Li, Catherine C.
    Yong, Christina M.
    Burningham, Zachary
    Gupta, Sumati
    Narayanan, Sujata
    Lin, Shih-Wen
    Carroll, Susheela
    Mhatre, Shivani K.
    Graff, Julie N.
    Dreicer, Robert
    Sauer, Brian C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (01) : 1.e1 - 1.e10
12345